Bocouture 200 IU

Bocouture® 200 IU is a prescription injectable formulation containing 200 International Units (IU) of incobotulinumtoxinA, a purified botulinum neurotoxin type A. It is used by qualified healthcare professionals for approved aesthetic treatments and, depending on the country, certain therapeutic indications. Bocouture is manufactured by Merz Pharmaceuticals. Bocouture Bocouture 200 IU is supplied as a sterile, freeze-dried (lyophilized) powder for reconstitution with sterile saline before injection. It is intended for administration only by licensed healthcare professionals experienced in botulinum toxin treatments. Unlike some other botulinum toxin products, Bocouture contains incobotulinumtoxinA without complexing proteins, resulting in a highly purified formulation.

Composition

Each 200 IU presentation typically contains:

• 200 International Units (IU) of incobotulinumtoxinA
• Human albumin
• Sucrose

The product is preservative-free and intended for single-patient use after reconstitution.

Storage Requirements

To maintain product quality:

• Store according to the manufacturer’s approved labeling.
• Protect from excessive heat and direct sunlight.
• Reconstitute only with sterile saline.
• Use the reconstituted solution within the manufacturer’s recommended timeframe.
• Follow aseptic handling procedures.

Safety Information

Bocouture is a prescription medicine and should only be administered by qualified healthcare professionals.

It may not be appropriate for individuals with:

• Known hypersensitivity to any component of the formulation
• Infection at the proposed injection site
• Certain neuromuscular disorders

Patients who are pregnant, breastfeeding, or have significant underlying medical conditions should consult a healthcare professional before treatment.

Possible side effects include:

• Injection-site pain or bruising
• Headache
• Temporary eyelid drooping
• Localized muscle weakness
• Swelling or redness at the injection site

Serious adverse reactions are uncommon but require prompt medical attention.

Mechanism of Action

Bocouture works by temporarily blocking the release of acetylcholine at the neuromuscular junction.

This action leads to:

• Temporary relaxation of targeted muscles
• Reduction of excessive muscle contractions
• Softening of dynamic facial wrinkles
• Temporary reduction of muscle overactivity in approved therapeutic indications

Product Features

• 200 IU potency
• Highly purified incobotulinumtoxinA
• Free from complexing proteins
• Sterile lyophilized powder
• Precise dosing by trained healthcare professionals
• Suitable for approved aesthetic and therapeutic applications
• Single-use vial

1. Highly Purified Formulation

Contains incobotulinumtoxinA without complexing proteins.

2. Minimally Invasive

Provides treatment without surgery.

3. Clinically Established

Botulinum toxin type A has been extensively studied for approved medical and cosmetic uses.

4. Temporary and Adjustable

Effects gradually diminish, allowing individualized retreatment schedules.

5. Broad Clinical Applications

Used in aesthetic medicine as well as selected neurological and rehabilitation settings where approved.

Cosmetic Applications

Depending on local regulatory approvals, Bocouture may be used to temporarily improve the appearance of:

• Glabellar (frown) lines
• Horizontal forehead lines
• Crow’s feet (lateral canthal lines)
• Other dynamic facial wrinkles as determined by a qualified healthcare professional

Therapeutic Applications

In some countries, the same active ingredient (incobotulinumtoxinA) is approved under different brand names for medical conditions such as:

• Cervical dystonia
• Blepharospasm
• Upper limb spasticity
• Lower limb spasticity
• Other approved neurological disorders

Approved indications vary by country and regulatory authority.

Typical Duration of Effect

Treatment results vary according to the indication, dosage, injection technique, and individual response.

Typical cosmetic outcomes:

• Initial improvement: 2–4 days
• Full effect: approximately 2 weeks
• Duration: approximately 3–4 months

Medical treatment intervals may differ depending on the condition being treated.